FDA Approves Sotorasib / Lumakras + Panitumumab / Vectibix for KRAS G12C Mutation Extending Survival Colorectal 3 Mins Read On January 16, 2025, a significant advancement in cancer treatment was announced. The FDA approved a new therapeutic option for…
EMBER-3 Reveal: Imlunestrant – Standalone Star or Team Player with Abemaciclib? Breast 2 Mins Read EMBER-3 Trial: Pioneering Results in Advanced Breast Cancer TreatmentThe results of the Phase 3 EMBER-3 trial were unveiled at the…
